913388-48-4

Usage

Uses

Since the provided materials do not specify any particular applications for 1H-Indole-1-carboxylic acid, 5-(4-Methyl-1-piperazinyl)-, 1,1-dimethylethyl ester, it is not possible to list its uses based on the given information. However, given its classification as an indole compound with a 4-methylpiperazine moiety, it may have potential applications in the pharmaceutical or chemical industries, possibly as an intermediate in the synthesis of drugs or other organic compounds. Further research and study would be required to determine its specific uses and applications.

Upstream product

• 109-01-3 1-methyl-piperazine 
• 374818-66-3 tert-butyl 5-iodo-1H-indole-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant academic research and scientific papers

JAK INHIBITOR

A JAK inhibitor comprising, as an active ingredient, a nitrogen-containing heterocyclic compound represented by formula (I) {wherein W represents a nitrogen atom or -CH-; X represents -C (=O) - or -CHR4- (wherein R4 represents a hydrogen atom, or the like); R1 represents the formula described below [wherein Q1 represents-CR8-(wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); Q2 represents -NR15- (wherein R15 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); and R5 and R6 may be the same or different and each represents a hydrogen atom, halogen, carboxy, substituted or unsubstituted lower alkyl, or the like], or the like; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof.

INDOLYL- PYRIDONE DERIVATIVES HAVING CHECKPOINT KINASE 1 INHIBITORY ACTIVITY

Compounds of formula (I) have checkpoint kinase 1 (CHK1 ) inhibitory activity: wherein R1, R2, R5 and R6 are independently selected from hydrogen, hydroxy, methyl, trifluoromethyl, hydroxymethyl, methoxy, triflu